Rocuronium 50 Iv Biotech Injection 10 mg. 50 mg Injection
PDF Leaflet Revision Date: 27 January 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunct to general anaesthesia for tracheal intubation and muscle relaxation.
Dosage (summary)
0.6 mg/kg for intubation; maintenance 0.15 mg/kg.
Onset of Action / Duration
Onset: 60-90 secs, Duration: 30-50 mins.
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
- Obesity
Pregnancy & Breastfeeding
Safety not established; use with caution in pregnancy and lactation.
Key Drug Interactions
- Halogenated volatile anaesthetics
- Aminoglycosides
- Corticosteroids
Contraindications
- Hypersensitivity to rocuronium
- Neonates
- Elderly and paediatric patients in ICU
Common side effects
- Injection site pain
- Tachycardia
- Prolonged neuromuscular block
Counselling Points
- Monitor for respiratory function post-administration.
- Avoid driving or operating machinery for 24 hours post-recovery.
- Report any signs of allergic reactions immediately.
Serious warnings
- Risk of anaphylaxis
- Prolonged paralysis in ICU
- Residual neuromuscular blockade
Important Disclaimer
The Rocuronium 50 Iv Biotech Injection 10 mg. 50 mg Injection professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
